About Technology Issues FAQ

Links

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.